Bank of New York Mellon’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $917K | Buy |
268,204
+8,412
| +3% | +$26.1K | ﹤0.01% | 3416 |
|
|
2026
Q1 | $592K | Sell |
259,792
-12,762
| -5% | -$29.4K | ﹤0.01% | 3517 |
|
|
2025
Q4 | $763K | Sell |
272,554
-88,166
| -24% | -$315K | ﹤0.01% | 3398 |
|
|
2025
Q3 | $1.73M | Sell |
360,720
-246,862
| -41% | -$1.57M | ﹤0.01% | 2886 |
|
|
2025
Q2 | $5.53M | Buy |
607,582
+48,117
| +9% | +$355K | ﹤0.01% | 2213 |
|
|
2025
Q1 | $5.05M | Sell |
559,465
-63,456
| -10% | -$670K | ﹤0.01% | 2215 |
|
|
2024
Q4 | $8.14M | Buy |
622,921
+35,105
| +6% | +$468K | ﹤0.01% | 2026 |
|
|
2024
Q3 | $9.22M | Sell |
587,816
-64,356
| -10% | -$975K | ﹤0.01% | 1978 |
|
|
2024
Q2 | $8.8M | Sell |
652,172
-5,897
| -0.9% | -$121K | ﹤0.01% | 2023 |
|
|
2024
Q1 | $18.2M | Sell |
658,069
-44,601
| -6% | -$990K | ﹤0.01% | 1630 |
|
|
2023
Q4 | $13.5M | Sell |
702,670
-55,970
| -7% | -$1.01M | ﹤0.01% | 1811 |
|
|
2023
Q3 | $12.3M | Sell |
758,640
-39,829
| -5% | -$707K | ﹤0.01% | 1823 |
|
|
2023
Q2 | $15.2M | Sell |
798,469
-3,565
| -0.4% | -$63.6K | ﹤0.01% | 1712 |
|
|
2023
Q1 | $11.7M | Sell |
802,034
-124,398
| -13% | -$2.23M | ﹤0.01% | 1853 |
|
|
2022
Q4 | $18.1M | Buy |
926,432
+73,510
| +9% | +$1.43M | ﹤0.01% | 1591 |
|
|
2022
Q3 | $20.6M | Sell |
852,922
-8,976
| -1% | -$277K | 0.01% | 1486 |
|
|
2022
Q2 | $27.1M | Sell |
861,898
-14,844
| -2% | -$538K | 0.01% | 1366 |
|
|
2022
Q1 | $38.6M | Sell |
876,742
-10,299
| -1% | -$442K | 0.01% | 1273 |
|
|
2021
Q4 | $38.6M | Sell |
887,041
-9,493
| -1% | -$372K | 0.01% | 1327 |
|
|
2021
Q3 | $28.1M | Buy |
896,534
+11,502
| +1% | +$453K | 0.01% | 1521 |
|
|
2021
Q2 | $37.5M | Buy |
885,032
+11,034
| +1% | +$429K | 0.01% | 1358 |
|
|
2021
Q1 | $32.9M | Sell |
873,998
-92,785
| -10% | -$2.9M | 0.01% | 1404 |
|
|
2020
Q4 | $26.2M | Buy |
966,783
+151,943
| +19% | +$3.91M | 0.01% | 1472 |
|
|
2020
Q3 | $20.5M | Sell |
814,840
-9,365
| -1% | -$137K | 0.01% | 1452 |
|
|
2020
Q2 | $6.28M | Sell |
824,205
-15,471
| -2% | -$113K | ﹤0.01% | 2096 |
|
|
2020
Q1 | $7.68M | Sell |
839,676
-96,318
| -10% | -$581K | ﹤0.01% | 1845 |
|
|
2019
Q4 | $4.84M | Sell |
935,994
-313,729
| -25% | -$2.01M | ﹤0.01% | 2358 |
|
|
2019
Q3 | $7.26M | Buy |
1,249,723
+21,895
| +2% | +$98.2K | ﹤0.01% | 2100 |
|
|
2019
Q2 | $3.93M | Buy |
1,227,828
+130,765
| +12% | +$446K | ﹤0.01% | 2453 |
|
|
2019
Q1 | $4.5M | Buy |
1,097,063
+199,836
| +22% | +$1.26M | ﹤0.01% | 2380 |
|
|
2018
Q4 | $5.68M | Sell |
897,227
-534,473
| -37% | -$5.55M | ﹤0.01% | 2204 |
|
|
2018
Q3 | $23.7M | Buy |
1,431,700
+52,294
| +4% | +$889K | 0.01% | 1518 |
|
|
2018
Q2 | $23.1M | Buy |
1,379,406
+25,438
| +2% | +$412K | 0.01% | 1516 |
|
|
2018
Q1 | $21.1M | Buy |
1,353,968
+17,991
| +1% | +$321K | 0.01% | 1545 |
|
|
2017
Q4 | $25.2M | Buy |
1,335,977
+239,877
| +22% | +$5.32M | 0.01% | 1428 |
|
|
2017
Q3 | $32M | Sell |
1,096,100
-1,583
| -0.1% | -$46.7K | 0.01% | 1263 |
|
|
2017
Q2 | $35.3M | Buy |
1,097,683
+5,844
| +0.5% | +$192K | 0.01% | 1192 |
|
|
2017
Q1 | $37.8M | Buy |
1,091,839
+43,445
| +4% | +$1.55M | 0.01% | 1138 |
|
|
2016
Q4 | $37M | Buy |
1,048,394
+136,971
| +15% | +$4.63M | 0.01% | 1134 |
|
|
2016
Q3 | $31.7M | Buy |
911,423
+12,065
| +1% | +$422K | 0.01% | 1153 |
|
|
2016
Q2 | $33.6M | Buy |
899,358
+18,943
| +2% | +$712K | 0.01% | 1086 |
|
|
2016
Q1 | $35.6M | Buy |
880,415
+22,254
| +3% | +$829K | 0.01% | 1042 |
|
|
2015
Q4 | $30.9M | Sell |
858,161
-90,679
| -10% | -$3.28M | 0.01% | 1105 |
|
|
2015
Q3 | $30.3M | Sell |
948,840
-46,876
| -5% | -$1.6M | 0.01% | 1141 |
|
|
2015
Q2 | $33.9M | Buy |
995,716
+31,133
| +3% | +$1.05M | 0.01% | 1133 |
|
|
2015
Q1 | $32.6M | Buy |
964,583
+44,452
| +5% | +$1.55M | 0.01% | 1149 |
|
|
2014
Q4 | $32.3M | Sell |
920,131
-47,669
| -5% | -$1.61M | 0.01% | 1145 |
|
|
2014
Q3 | $31.7M | Sell |
967,800
-40,746
| -4% | -$1.39M | 0.01% | 1137 |
|
|
2014
Q2 | $34.3M | Sell |
1,008,546
-22,430
| -2% | -$769K | 0.01% | 1133 |
|
|
2014
Q1 | $36.1M | Buy |
1,030,976
+22,912
| +2% | +$808K | 0.01% | 1091 |
|
|
2013
Q4 | $36.9M | Sell |
1,008,064
-5,085
| -0.5% | -$187K | 0.01% | 1065 |
|
|
2013
Q3 | $35M | Buy |
1,013,149
+65,642
| +7% | +$2.3M | 0.01% | 1060 |
|
|
2013
Q2 | $32.1M | Buy |
+947,507
| New | +$31.4M | 0.01% | 1078 |
|
Other funds holding ACH
CCM
ICM
PCMI
Bank of New York Mellon's ACH Position: Q2 2026 in Review
Bank of New York Mellon increased its Accendra Health (ACH) stake by 3.2% in Q2 2026, buying an estimated $26.1K and bringing the position to 268,204 shares worth $917K. The position accounts for ﹤0.01% of the portfolio, ranked #3416.
Bank of New York Mellon first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $38.6M in Q1 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Bank of New York Mellon held 268,204 shares of Accendra Health worth $917K as of Q2 2026.
- Bank of New York Mellon bought 8,412 Accendra Health shares in Q2 2026, an estimated $26.1K.
- Accendra Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3416 holding.
- Bank of New York Mellon first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Accendra Health position peaked at $38.6M in Q1 2022.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.